November 6, 2012 ·
Leave a comment
November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of excellence in women’s health with an international biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products aimed at improving the health of women, approached Thought Leader Select for support in a variety of collaborative efforts with leading physicians and other health care professionals at leading universities, medical schools, teaching hospitals, and specialty clinics. The key opinion leaders represent medical experts within the Canadian obstetrics and gynecology community, with areas of sub-specialty including fertility and the treatment of uterine tumors.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, to advance the science of medicine and patient care in women’s health, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening collaborative ... read more »
TAGS: 
biopharmaceutical company biotechnology Canadian KOLs centers of excellence Chapel Hill NC clinical research clinical trials deep-profiling drug development gynecology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs Kristen Smithwick medical experts medical research obstetrics scientific journal publishing Thought Leader Select thought leaders transparency treatment guidelines uterine tumors women's health
October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
October 4, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with scientific advisory boards, consulting, and medical science liaison outreach to leading physicians in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes, the company has now chosen Thought Leader Select to pinpoint the leading experts in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the area of obesity, and a suite of tools to promote collaborative work ... read more »
TAGS: advisory boards biopharmaceutical biotechnology Brian Castle clinical research drug development health care professionals health care providers healthcare key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts medicine obesity obesity key opinion leaders obesity specialists public health
September 27, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating type and type II diabetes, approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form a roster of key opinion leaders in Canadian endocrinology circles, the company will round out its roster of key opinion leaders by deploying Thought Leader Select’s team to assess the skills and experiences of registered nurses and clinical pharmacists around the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of registered nurses and pharmacists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.
“Thought ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology clinical pharmacists clinical research clinical trials deep-profiling diabetes health care professionals health care providers key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling medical experts Neil Mellor pharmaceuticals registered nurses Thought Leader Select type 1 diabetes type 2 diabetes
June 21, 2012 ·
Leave a comment
June 21, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top 10 global biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating exocrine pancreatic insufficiency (EPI), approached Thought Leader Select for support with scientific advisory boards in support of a new product initiative. To meet the strategic needs of the company’s advisory board activities in support of the new treatment, Thought Leader Select will deploy its in-house research group for an assessment of community-based key opinion leaders in gastroenterology throughout the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in multiple areas where they advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
For the national assessment, the Thought Leader Select research group will collaborate with a team of national key opinion leaders in gastroenterology to identify community-based physicians for grassroots-level scientific advisory work. Thought Leader Select will combine the key opinion leader recommendations with the experience data to optimize a pool of leading physicians with broad representation across multiple geographic ... read more »
TAGS: advisory boards biopharmaceutical clinical research community-based gastroenterologists EPI exocrine pancreatic insufficiency gastroenterology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts pharmaceutical physicians therapeutic areas Thought Leader Select
June 14, 2012 ·
Leave a comment
June 14, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a global engagement in blood disorders with a top 30 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for a product in development to treat iron overload in the body, approached Thought Leader Select for support with its launch activities across multiple global markets. To meet the strategic needs of the company’s pre-launch for a new blood disorders treatment, Thought Leader Select will deploy its in-house research group for an assessment of key opinion leaders in the area of chelation therapy.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following geographic areas:
- United States
- Europe
- Japan
- Pacific Rim
- Middle East
For the global assessment, the Thought Leader Select research group will identify 100 physicians appropriate for compliant engagement in support of drug development for blood disorders.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology blood disorders chelation therapy clinical research clinical trials drug development drug launch iron overload key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL profiling KOL reserch Kristen Smithwick medical congresses medical experts Neil Mellor pharmaceutical physicians scientific journal publishing Thought Leader Select treatment guidelines
March 14, 2012 ·
Leave a comment
Industry Insights from Brian Castle
As in nearly all other aspects of life, social media is fast becoming a dominant force in the world of healthcare. Leading centers of excellence—hospitals, clinics, research foundations, and universities—are utilizing social media to educate patients about medical resources and treatments on a daily basis. Biopharmaceutical companies are using social media to promote new medications and further educate patients about other wellness resources at their disposal to help with debilitating diseases and conditions.
Physicians and other healthcare professionals, like practically every other profession, are embracing social media at unprecedented levels, engaging with each other on everything from new medical devices to tough medical cases. Due to this rise in HCP use of social media, some have begun to question the very essence of what makes a key opinion leader in the medical profession.
Some of these questioners have gone a step farther, at their ultimate peril, in misinterpreting physician involvement in spaces like Twitter, Facebook, LinkedIn and physician-only social media networks like Sermo. They incorrectly perceive that social media participation is the new thought leadership. Last year, I sat in the audience for a presentation by a leader in the pharmaceutical industry. This person posited a talking point she’d heard from an executive at a physician-only social media network: “If you’re not in their social network, you’re not ... read more »
TAGS: basic research biopharmaceutical companies biotechnology Brian Castle centers of excellence clinical research diseases Facebook global KOL HCPs health care professionals healthcare hospitals key opinion leaders KOL engagement KOL identification KOLs LinkedIn local KOL medical clinics medical conditions medical congresses medical devices medical diagnostics medical meetings medical resources medical treatment options medications national KOL patient education pharmaceuticals physician-only social networks physicians public health regional KOL research foundations scientific journal publishing Sermo social media thought leader engagement thought leader identification Thought Leader Select thought leaders thought leadership treatment guidelines Twitter universities wellness
March 7, 2012 ·
Leave a comment
Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement a research assessment of key opinion leaders and centers of excellence in the treatment area of women’s health. The company will perform the assessment for a top-50 global biopharmaceutical firm entering the treatment of conditions affecting women.
For the assessment, Thought Leader Select will use its proprietary KOL identification and profiling methodology, known as deep profiling, to pinpoint 100 U. S. key opinion leaders in women’s health, with specialty in the area of obstetrics and gynecology. The company will then study the skills and experience of American OB/GYNs in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.
The client company will utilize Thought Leader Select’s findings to engage key opinion leaders in obstetrics and gynecology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.
In addition to assessing OB/GYN KOLs in the United States, Thought Leader Select will also apply its objective, validated methodology to identify and profile 50 American centers of excellence in the area of women’s health. For the centers of excellence assessment, Thought Leader Select will gauge each center’s community footprint of associated physicians and ... read more »
TAGS: advisory boards area of expertise associated clinics basic research biopharmaceutical industry biotechnology breast cancer centers of excellence cervical cancer clinical research gynecology healthcare key opinion leaders KOL engagement KOL identification KOL profiling KOLs medical science liaisons Neil Mellor OB/GYN OB/GYN KOLs obstetrics ovarian cancer pharmaceuticals physicians scientific journals Thought Leader Select thought leaders thought leadership women's health
February 16, 2012 ·
Leave a comment
Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement of a key opinion leader assessment for a top five global pharmaceutical company.
For the assessment, Thought Leader Select will use its proprietary identification methodology to pinpoint 40 Canadian key opinion leaders in oncology, with sub-specialty in the area of skin cancer. The company will study the skills and experience of Canadian oncologists in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.
The client company will utilize Thought Leader Select’s research to engage key opinion leaders in oncology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.
“We are excited about this opportunity to support a great company as they prepare to enter the Canadian market with a new medicine that will improve the lives of patients suffering from skin cancer,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “Our position in the advancement of this new treatment is critical, since our work ensures that the company will be reaching out to the right physicians during the company’s earliest phase of assisting in the treatment of patients in this disease area.”
About Neil Mellor
Neil Mellor is ... read more »
TAGS: basic research biopharmaceutical industry Canadian key opinion leaders clinical research healthcare key opinion leader assessment KOL engagement KOL identification KOLs medical research medical science liaisons medicine MSLs Neil Mellor oncologists Oncology pharmaceuticals physician public health publishing scientific advisory boards scientific journals skin cancer therapeutic area Thought Leader Select
February 2, 2012 ·
Leave a comment
New Press Release from the Offices of Thought Leader Select
February 2, 2012 (Chapel Hill, NC) Thought Leader Select is pleased to announce a pair of key opinion leader (KOL) identification and profiling projects to support the development pipeline of a leading pharmaceutical client focused in the therapeutic area of gastroenterology.
In the first research assessment, Thought Leader Select will identify and profile leading medical experts in the treatment of patients suffering from non-cancer-related chronic pain. The company will identify the leading pain experts throughout the United States by examining the skills and experiences of physicians in multiple disciplines and specialties, including gastroenterologists, primary care physicians, nurse practitioners, and physician assistants.
For the second research assessment, Thought Leader Select will identify and profile 100 key opinion leaders in colorectal surgery, as well as 125 KOLs in gastroenterology. The cumulative group of 225 physician thought leaders will share vast experience in research and treatment of fecal incontinence.
Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders chronic pain, colorectal surgery, and gastroenterology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research. The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in ... read more »
TAGS: basic and clinical research chronic pain clinical research colorectal surgery deep-profiling drug development pipeline gastroenterology key opinion leaders KOL late-stage clinical trials medical experts medical research medicine nurse practitioners patient treatment Paul Meade pharmaceuticals physician assistants physicians primary care physicians publishing scientific advisory boards scientific journals therapeutic area Thought Leader Select thought leaders
Older posts »
